衰弱与晚期心衰患者左心室辅助装置植入后临床结局的系统综述与荟萃分析
该系统综述与荟萃分析纳入13项研究共3435例接受左心室辅助装置(LVAD)植入的晚期心衰患者,比较衰弱与非衰弱患者的临床结局。结果显示衰弱患者拔管时间和住院时间显著延长,且衰弱预测长期死亡风险增加,但不预测住院或短期死亡。
要点
- 衰弱患者LVAD植入后拔管时间平均延长45±6小时。
- 衰弱患者住院时间平均延长2.9±1.2天(P=.001)。
- 衰弱预测长期死亡风险增加(HR 1.44,95%CI 1.15-1.80;P=.001)。
核心结论
- 衰弱导致LVAD植入的晚期心衰患者拔管时间、住院时间显著延长及长期死亡风险增加。
- 考虑LVAD植入的老年患者应评估衰弱状态,并向患者说明衰弱增加不良结局风险。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed和Embase至2017年9月11日。
- 最终纳入13项研究共3435例患者(平均年龄57.7±15.3岁,79%男性,随访13±14个月)。
主要发现
- 衰弱患者(n=579)较非衰弱患者(n=2721)拔管时间延长(3项研究;平均差45±6小时;I2=0%)。
- 衰弱患者住院时间延长(4项研究;平均差2.9±1.2天;P=.001;I2=21%)。
- 衰弱不预测住院或短期死亡(3项研究;HR 1.22,95%CI 0.66-2.26;P>.05;I2=0%)。
- 衰弱预测长期死亡(7项研究;HR 1.44,95%CI 1.15-1.80;P=.001;I2=0%)。
临床怎么用
- 对考虑LVAD植入的老年患者应进行衰弱评估。
- 向患者解释手术风险与获益时,应强调衰弱增加不良临床结局的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty has been identified as a risk factor for adverse clinical outcomes after cardiac intervention or surgery. However, whether it increases the risk of adverse outcomes in patients undergoing left ventricular assist device (LVAD) therapy has been controversial. Therefore, we conducted a systematic review and meta-analysis of the frailty measures and clinical outcomes of length of stay and mortality in this setting. METHODS: PubMed and Embase were searched until September 11, 2017, for studies evaluating the association between frailty and clinical outcomes in advanced heart failure patients undergoing LVAD implantation. RESULTS: A total of 46 and 79 entries were retrieved from our search strategy. A total of 13 studies involving 3435 patients were included in the final meta-analysis (mean age: 57.7 ± 15.3 years; 79% male, follow-up duration was 13 ± 14 months). Compared to nonfrail patients (n = 2721), frail patients (n = 579) had significantly longer time-to-extubation (n = 3; mean difference: 45 ± 6 hours; I2: 0%) and hospital length of stay (n = 4; mean difference: 2.9 ± 1.2 days; P = .001; I2: 21%). Frailty was not a predictor of inpatient or short-term mortality [n = 3; hazard ratio (HR): 1.22, 95% confidence interval (CI): 0.66-2.26; P > .05; I2: 0%] but predicted long-term mortality (n = 7; HR: 1.44, 95% CI: 1.15-1.80; P = .001; I2: 0%). CONCLUSIONS: Frailty leads to significantly longer time to extubation, hospital length of stay, and long-term mortality in advanced heart failure patients who have undergone LVAD implantation. Older patients being considered for LVAD implantation should therefore be assessed for frailty status. The risk and benefit of the procedure should be explained to the patient, emphasizing that frailty increases the likelihood of adverse clinical outcomes.
引用
- Tse G, Gong M, Wong SH, et al. Frailty and Clinical Outcomes in Advanced Heart Failure Patients Undergoing Left Ventricular Assist Device Implantation: A Systematic Review and Meta-analysis. J Am Med Dir Assoc. 2017. PMID: 29129497. doi:10.1016/j.jamda.2017.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。